Home Afamelanotide Corporate Investors Videos FAQs Contact

Clinuvel is Australia’s photoprotective company. Clinuvel's focus is to gain market approval for afamelanotide, a drug to manage the symptoms of severe sufferers of UV and light related skin disorders. The global team at Clinuvel is excited by, and committed to, the prospect of being able to treat diseases and patients who have not been able to receive effective medicinal relief. More...

Clinuvel Photoprotection

Photoprotection is protection from light and ultraviolet radiation. A global leader in photoprotection of skin, Clinuvel seeks to share and expand its knowledge online. Clinuvel Photoprotection is an online resource library on UV, light, skin and melanin knowledge, allowing interaction with medical professionals on related topics, and engaging thought-leaders in discussions on wider issues. Visit the Clinuvel Photoprotection site...

Our Mission

Clinuvel believes afamelanotide can provide photoprotection to patients worldwide who suffer from UV and light related skin disorders. Clinuvel’s clinical program with afamelanotide is designed to assist those patients who are most severely affected by UV and light, with the aim of improving their quality of life. More...